Cargando…
Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study
SUMMARY: BACKGROUND: Unwanted submental fat (SMF) is aesthetically unappealing, but methods of reduction are either invasive or lack evidence for their use. An injectable approach with ATX-101 (deoxycholic acid) is under investigation. OBJECTIVES: To evaluate the efficacy and safety of ATX-101 for t...
Autores principales: | Rzany, B, Griffiths, T, Walker, P, Lippert, S, McDiarmid, J, Havlickova, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232897/ https://www.ncbi.nlm.nih.gov/pubmed/24147933 http://dx.doi.org/10.1111/bjd.12695 |
Ejemplares similares
-
Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study
por: Ascher, B, et al.
Publicado: (2014) -
Results from a Pooled Analysis of Two European, Randomized, Placebo-Controlled, Phase 3 Studies of ATX-101 for the Pharmacologic Reduction of Excess Submental Fat
por: McDiarmid, James, et al.
Publicado: (2014) -
Abstract: Alopecia in Male Patients Treated with ATX-101 (Deoxycholic Acid) for Submental Fullness
por: Shridharani, Sachin M., et al.
Publicado: (2017) -
An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
por: Khan, Husnain, et al.
Publicado: (2023) -
Abstract: Novel Expanded Safe Zone System for Treatment of Submental Fullness with ATX-101 (Deoxycholic Acid)
por: Shridharani, Sachin M., et al.
Publicado: (2017)